Navigation Links
3 studies confirm the value of etanercept therapy in treating juvenile idiopathic arthritis
Date:6/12/2009

Copenhagen, Denmark, Friday 12 June 2009: Three new studies have individually shown the anti-TNF (tumour necrosis factor) therapy etanercept to be effective, with a good safety profile, in children under four years of age with juvenile idiopathic arthritis (JIA), and associated with improved Health-Related Quality of Life (HRQoL) in a substantial proportion of children with JIA. The data are being presented at the Paediatric Rheumatology European Society Congress (PReS) 2009, a joint congress with the 2009 Congress of the European League Against Rheumatism (EULAR) in Copenhagen, Denmark.

The first study, conducted in Italy, showed entanercept to be effective, with a good safety profile, in children under four years of age (an as yet unlicensed patient population for the treatment). Thirty-three patients under four years of age with unresponsive JIA (24 female, 9 male) were treated with etanercept for an average of 23 months. After the first 6 months of treatment, 82% achieved the ACR Pedi 30* response and 48% achieved the ACR Pedi 70* response. There was a low rate of mild adverse events, whilst one patient temporarily suspended treatment following hospitalisation for an infection.

The second study, conducted in The Netherlands, from the Arthritis and Biological in Children (ABC) project, observed impressive improvements in the Health-Related Quality of Life (HRQoL) of 53 patients with previously refractory (unresponsive) JIA in seven Dutch centres during entanercept use of at least 27 months. These comprised both disease-specific improvements (inflamed joints, functional impairment, erythrocyte sedimentation rate (ESR), a laboratory marker of inflammation) (p<0.001) and all generic HRQoL outcomes impaired by JIA (including pain, movement and dexterity) (p<0.05).

The third study, also from The Netherlands ABC-project, showed that a substantial 57% of non-responders to etanercept at three months (12 patients from 21 non-responders of a t
'/>"/>

Contact: Rory Berrie
eularpressoffice@uk.cohnwolfe.com
44-789-439-6425
European League Against Rheumatism
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Press Releases on BPA Studies By-Pass Scientific Process
2. Studies Report More Harmful Effects From BPA
3. Studies Highlight a Revolutionary New Method of Treating Post-Operative Bruising
4. ACTEMRA(R) (tocilizumab) Studies to be Featured at the European League Against Rheumatism (EULAR) Congress
5. AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances
6. Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association
7. Genomic Health to Present Multiple New Studies at the American Society of Clinical Oncology Annual Meeting
8. Studies Reveal Exposure to Pesticides During Pregnancy Increases Risk of Premature Birth, Low-Birth Weight, Neurological Problems and Diabetes
9. Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Sarcoma and Osteosarcoma: Phase I/II and Phase II Studies, ASCO 2009
10. 2 studies examine medical consequences of police use of force during restraint
11. Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...O, Nov. 30 Three decades ago, a st...g swallowed by children, prompting a switch by U.S...d today at the annual meeting of the Radiological ... tabs are still potentially unsafe. ,, "One of ... can construction in the U.S. was to eliminate ina...
(Date:11/30/2009)...RALEIGH, N.C., Nov. 30 Raleigh de...s have launched a new plan to educate the communit...ny benefits. ,, Through a series of free educat...n is taking a lead role in educating the public ab...The series of sedation dental care educational vid...
(Date:11/30/2009)... proportion of patients who undergo abdominal/pelv...d unnecessary additional image acquisition resulti...ing to a study presented today at the annual meeti...SNA). , "It is the responsibility of all physici...t the dosage is as low as reasonably achievable wi...
(Date:11/29/2009)...eaths from cancer in Europe show a steady decline ...0-2004. Deaths from all cancers in the European Un...rcent in men and eight percent in women, with a la... a study published online in the cancer journal, ..., researchers found that there was an average 185....
(Date:11/29/2009)... The Academy of General Dentistry (AGD) ann... received the Mastership Award during the AGD,s co..., commitment to excellence in dental education.,T...s of approved continuing dental education in the 1...dicated to hands-on skills and techniques. , ...
Breaking Medicine News(10 mins):Health News:Beverage Can Stay-Tabs Pose Swallowing Risk 2Health News:Raleigh Dentist Dr. Robert Williamson to Educate Patients About Sedation Dentistry 2Health News:Unindicated CT series result in unnecessary radiation exposure for patients 2Health News:Unindicated CT series result in unnecessary radiation exposure for patients 3Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 2Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 3Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 4Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 5Health News:Orange County Dentist Honored by The Academy of General Dentistry 2
...(Amex:,ULU) announced today that its Board of Dire...fer, whereby the Company will offer to purchase sh...s of common stock. This,program reflects ULURU,s d...m selling small lots of stock. The,Company will pa...
...lford, MD, an associate professor of medicine at B...ng physician in the General Internal Medicine Depa...e medical director of the Substance Abuse Preventi...ard was presented at the American Association for ...
... limiting bariatric surgeries to high-volume cente... underinsured patients, populations which are amon...Southwestern Medical Center researchers shows. , ...nd Medicaid because some studies have identified b...
...ll/ - Novadaq(R) Technologies Inc.,(TSX: NDQ), a d...image guided,therapies for the operating room, wil...ss the financial results for the third quarter end... Taped replay: 416-640-1917 or 1-877-289-8525 (...
...ck Exchange Symbol: CYT, MONTREAL, Oct. 30 /PRNew...: CYT), the global leader in cryotherapy products ... Jan Keltjens, President and CEO of,CryoCath, will...porate update, as well as provide updates on the S...
... and Oral-B Triumph with SmartGuide to, Present t...and Grant One Lucky Winner the Make...al-B(R),s new Triumph with,SmartGuide has partnere...tance of maintaining their oral health. Oral-B,and...
Other Medicine News:Health News:ULURU Inc. Announces Odd-Lot Buy Back Offer 2Health News:Government restrictions on weight loss surgeries limit access for poor, underinsured patients 2Health News:Government restrictions on weight loss surgeries limit access for poor, underinsured patients 3Health News:Novadaq announces third quarter 2007 conference call and webcast 2Health News:Novadaq announces third quarter 2007 conference call and webcast 3Health News:CryoCath to present at CIBC Healthcare Conference 2Health News:Actress and Author Mariel Hemingway Guides Boomers on How to Make Their 'Third Age' a Healthy Age 2Health News:Actress and Author Mariel Hemingway Guides Boomers on How to Make Their 'Third Age' a Healthy Age 3
(Date:11/29/2009)...-- FUJIFILM Medical Systems USA, Inc. is pleased t...nel DR cassette, at the 2009 Radiological Society ... any clinical environment, FDR D-EVO uses an innov...jifilm,s trademark image quality and outstanding f... to transition to DR without modification to the e...
(Date:11/28/2009).../ -- Siemens Healthcare redefines productivity wi...ing matrix) technology and with its new Dot(TM) (D...s are introduced in the new MAGNETOM ® Aera*...ners at the 95th Scientific Assembly and Annual Me... (RSNA) from November 29 to December 3 at McCormic...
(Date:11/26/2009)..., Nov. 26 The 2009 Frost & Sul...e Generic Pharmaceutical Market is presented to Ci...p://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )...owing criteria were used to benchmark Cipla Medpro...ategy and implementation, degree of innovation in ...
Breaking Medicine Technology:FUJIFILM's DR Cassette Makes World Debut 2Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 7Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Berkeley researchers take the lead out of piezoelectrics 14835 1Berkeley researchers take the lead out of piezoelectrics 14835 2Berkeley researchers take the lead out of piezoelectrics 14835 3Journal of Hospice 26amp 3B Palliative Nursing Names New Editor 61352 1Journal of Hospice 26amp 3B Palliative Nursing Names New Editor 61352 2Journal of Hospice 26amp 3B Palliative Nursing Names New Editor 61352 3Healthcare Trust of America Inc Executes Agreement to Acquire a 62 000 SF Medical Office Building Located in Baltimore Maryland 61350 1Healthcare Trust of America Inc Executes Agreement to Acquire a 62 000 SF Medical Office Building Located in Baltimore Maryland 61350 2Healthcare Trust of America Inc Executes Agreement to Acquire a 62 000 SF Medical Office Building Located in Baltimore Maryland 61350 3
...ry thermometer designed to take body temperature, ...- Kidz-Med, Inc.,(subsidiary of American Scientifi...distributor of the Thermofocus(R) 5-in-1 non-conta... of a clinical study,conducted by the Second Child... Italy, which proves that the Thermofocus(R) measu...
...s First Approved Systemic Therapy to Treat the Dis...23 ,Bayer HealthCare Pharmaceuticals and Onyx Phar...hat The New England Journal of Medicine published,...var(R) (sorafenib),tablets decreased the absolute ...ectable hepatocellular carcinoma (HCC), or liver c...
Other Medicine Technology:Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6
Perclose ProGlide Suture-Mediated Closure
...f todays cardiac surgery patients require progress...d speedy return to everyday life. Since the intro...nicians have been able to provide nearly 400,000 C... Faster ambulation , Shorter hospital stays ,...
...DSi is an all-digital Fundus camera system that of... an efficient workflow. The Canon CF-60DSi come...es SLR digital camera features a "full frame CMOS ...ew ICG unit, which features a near-infrared digita...
...erts are an ophthalmologic medical device designed...1.00 to -3.00 diopters.* When placed in the cornea... zone, the product reshapes the anterior surface o...escription inserts, each having an arc length of 1...
Medicine Products: